- 12 August 2019
- 3 min read
AI shows promise in telling types of breast cancer apart
Researchers use machine learning to analyse biopsies and recognise complex patterns that can be difficult for pathologists.

The power of artificial intelligence is challenging pathologists in their ability to detect and diagnose some forms of breast cancer.
Researchers in the US have been testing how machine learning could help to read biopsies thanks to its ability to recognise complex patterns that can be a challenge for humans.
“Medical images of breast biopsies contain a great deal of complex data and interpreting them can be very subjective,” said Dr Joann Elmore, lead author of the study published in the JAMA Network Open journal.
“Distinguishing breast atypia from ductal carcinoma in situ (DCIS) is important clinically but very challenging for pathologists.
“Sometimes, doctors do not even agree with their previous diagnosis when they are shown the same case a year later.”
The team supplied its artificial intelligence system with 240 breast biopsy images linked to several types of breast lesions, with its readings compared against diagnoses made by 87 practicing pathologists.

It found that AI came close to performing as well as human doctors in differentiating cancer from non-cancer cases, but the machine managed to outperform doctors when differentiating DCIS from atypical hyperplasia.
“These results are very encouraging,” added Dr Elmore, a professor at the University of California, Los Angeles.
“It is critical to get a correct diagnosis from the beginning so that we can guide patients to the most effective treatments.”
With further improvements, researchers hope AI could be a vital tool in aiding pathologists, and are looking at how it could be used to diagnose melanoma next.
Earlier this week, the Department of Health announced that the NHS will receive a £250 million boost to build artificial intelligence that could help treat conditions including cancer.
The money will be invested in a new National Artificial Intelligence Lab which could help tackle some of the biggest challenges facing the NHS, including improving cancer screening, identifying patients most at risk of dementia or heart disease, and automating admin tasks, giving medical professionals more time with patients.
Related stories
• Blood test can detect return of breast cancer months before symptoms emerge
Nurses.co.uk editorial team
About the author
Nurses.co.uk editorial team
Bringing you a daily update of nursing, NHS, health and social care news from around the UK.
Want to get involved in the discussion
Sign In JoinRead something else
Covid-19 Didn’t Bring Retired Nurses Back – But It Is Highlighting A Deeper Problem
NHS England has revealed only 1,007 former nurses out of 71,000 returned to work last summer while Covid-sickness absence left hospitals with a net drop of 3,694 full-time nurses.
A Day In The Life Of A Student Nurse During The Pandemic
Student Nurse, Kyle, gives an insight into Student Nursing during the pandemic with a video diary outlining coursework, working from home and student cuisine.
What Band 5 Salary Nurses Get Paid In 2021 – And What You’ll Do To Earn It
The New Pay Deal for the NHS was signed in 2018 and ensured a minimum pay increase for all nurses at all bandings over the subsequent three years. Here’s what it means for Band 5 nurses.
Latest Jobs
Dialysis Nurse
Redditch, Worcestershire, England
TTM Healthcare
Renal Nurse
Redditch, Worcestershire, England
Time Recruitment Solutions
Chemotherapy Staff Nurse
Fazakerley, Liverpool, Merseyside, England
Clatterbridge Cancer Centre NHS Foundation Trust
Staff Nurse - Endoscopy
Manchester, Greater Manchester, England
Manchester University NHS Foundation Trust
Discharge Nurse
Epsom, Surrey, England
Epsom & St Helier University Hospitals NHS Trust
Staff Nurse
Margate, Kent, England
Kent & Medway NHS & Social Care Partnership Trust
See all of our RGN jobs
5789 jobs currently available